Skip to main content

Table 2 Surgical characteristics of the patients

From: Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure

Characteristic Conventional Levosimendan P value
CABG 17 6 0.84
AVR 2 1 0.79
MVR 4 1 0.71
CABG + VR 6 1 0.36
Duration of CPB (minutes) 170 ± 70a 176 ± 101a 0.65
Duration of AO (minutes) 69 ± 60a 80 ± 81a 0.76
LVAD 22 7 0.70
RVAD 5 1 0.95
BiVAD 2 1 0.86
Duration of AD (days) 3.2 ± 2a 3.8 ± 1.5a 0.20
  1. aMean ± standard deviation. Mann-Whitney U test was used to calculate p-values between the groups (duration data). Chi square test was used to compare categorial data. AO, aortic cross clamping; AVR, aortic valve replacement; BiVAD, biventricular ventricular assist device; CABG, coronary artery bypass grafting; CABG + VR, CABG combination with a valve replacement; CPB, cardiopulmonary bypass; IABP, intra-aortic balloon pump counter-pulsation; LVAD, left ventricular assist device; MVR, mitral valve replacement; RVAD, right ventricular assist device.